We have observed
7 EP applications
Richard Abraham Verhage
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
January 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS-BASED VACCINES
BATCHES OF RECOMBINANT ADENOVIRUS WITH ALTERED TERMINAL ENDS
HUMAN SERUM ALBUMIN BINDING COMPOUNDS AND FUSION PROTEINS THEREOF
NOVEL BISPECIFIC BINDING MOLECULES WITH ANTITUMORAL ACTIVITY
PNEUMATIC ALTERNATING PRESSURE MEMBRANE CELL SEPARATION SYSTEM
ADENOVIRUS SEROTYPE 26 AND SEROTYPE 35 FILOVIRUS VACCINES
THERAPEUTIC HPV16 VACCINES